Cellectar Biosciences, Inc. (CLRB) Operating cash flow 2016–2025
Cellectar Biosciences, Inc. (CLRB) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$23.1MFY2025 · since FY2016: -$8.3M → -$23.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$23.1M | +51.4% |
| FY2024 | -$47.6M | -47.0% |
| FY2023 | -$32.4M | -28.4% |
| FY2022 | -$25.2M | -11.8% |
| FY2021 | -$22.6M | -62.0% |
| FY2020 | -$13.9M | -19.1% |
| FY2019 | -$11.7M | -2.2% |
| FY2018 | -$11.4M | -3.8% |
| FY2017 | -$11.0M | -33.1% |
| FY2016 | -$8.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice